Axsome Therapeutics (19X.STU) Q3 2026 Earnings

10AugConfirmed
Q2 2026
Next
-1.08
-0.96
-0.84
-0.72

Details

Expected EPS
-0.72657659016
Actual EPS
N/A
Surprise EPS
0.73
Surprise Percent
+100%

Description

Axsome Therapeutics (19X.STU) will report earnings of for Q3 2026 on August 10, 2026.

0 Comments

Share your thoughts